Speaker Profile


Dr. Shuguang Huang

Chief Scientific Officer, Stat4ward

Dr. Shuguang Huang has 20 years of experience working in pharmaceutical and diagnostic companies. He had assumed technical and management positions at Eli Lilly, Wyeth, Pfizer, and Precision Therapeutics, a cancer diagnostic company. In 2014, he co-founded and assumed the Chief Scientific Officer position for the statistics consulting company Stat4ward LLC.

His expertise includes (i) In-depth real-life expertise in assay development and validation. (ii) biomarker development and exploratory analysis. (iii) CMC and statistical process control.

Dr. Huang is actively involved in guideline development committees of Clinical Laboratory Standard Institute (CLSI) and he is a committee member of American Association of Pharmaceutical Scientists (AAPS) Flow cytometry Action Programming Committee.

  •  Thursday, November 29, 2018
  • 10:00 AM PST | 01:00 PM EST,
  • 60 Minutes
  • ¤150.00
Statistics in Non-Clinical Development

In this webinar, I will give an overview of the use of statistics in different non-clinical fields, which mainly include

  •  Wednesday, December 5, 2018
  • 10:00 AM PST | 01:00 PM EST,
  • 60 Minutes
  • ¤150.00
Statistical Quality Control in Pharmaceutical and IVD Industries

Process validation is the establishment of documented evidence which provides a high degree of assurance that a specific process will consistently produce a product meeting its pre- determined specifications and quality characteristics.

  •  Monday, December 10, 2018
  • 09:00 AM PST | 12:00 PM EST,
  • 3 Hours
  • ¤290.00
3-Hour Virtual Seminar - Assay Validation According to CLSI Guidelines

Bioassay development and validation is very critical in pre-clinical drug discovery, clinical biomarker and translational research, diagnostic product (including companion diagnostic) development. In this presentation, overview if given for the terminologies, the scientific principles, and the regulatory guidelines that are related to assay validation.

  •  Friday, January 25, 2019
  • 10:00 AM PST | 01:00 PM EST,
  • 2 Hours
  • ¤190.00
2-Hour Virtual Seminar - Biomarker Development and Validation - A Statistical Perspective

Biomarker is very critical in pre-clinical drug discovery, clinical translational research, diagnostic product (including companion diagnostic) development. This webinar will focus on three areas:

View All



  • Recorded
  • View Anytime
  • 2 Hours
  • ¤240.00
2-Hour Virtual Seminar - Biomarker Development and Validation - A Statistical Perspective

Biomarker is very critical in pre-clinical drug discovery, clinical translational research, diagnostic product (including companion diagnostic) development. This webinar will focus on three areas:

  • Recorded
  • View Anytime
  • 3 Hours
  • ¤340.00
3-Hour Virtual Seminar - Assay Validation According to CLSI Guidelines

Bioassay development and validation is very critical in pre-clinical drug discovery, clinical biomarker and translational research, diagnostic product (including companion diagnostic) development. In this presentation, overview if given for the terminologies, the scientific principles, and the regulatory guidelines that are related to assay validation.

  • Recorded
  • View Anytime
  • 60 Minutes
  • ¤190.00
Statistics in Non-Clinical Development

In this webinar, I will give an overview of the use of statistics in different non-clinical fields, which mainly include

  • Recorded
  • View Anytime
  • ¤190.00
Statistical Quality Control in Pharmaceutical and IVD Industries

Process validation is the establishment of documented evidence which provides a high degree of assurance that a specific process will consistently produce a product meeting its pre- determined specifications and quality characteristics.

View All

Payment Methods

Contact Us

NetZealous LLC,
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA.

Information

  Refund Policy
  +1-800-447-9407
  support@compliance4All.com